egnite Introduces Customer Access to Its National Cardiovascular Registry and Launches 2026 Call for Science Investigator-Initiated Study Program

egnite, Inc., a leading cardiovascular digital health company, today announced two initiatives designed to enable independent, real-world cardiovascular research using its national de-identified Registry.

Effective immediately, CardioCare customers that contribute data to the egnite Registry will receive two complimentary Registry access licenses included as part of their CardioCare subscription.

In parallel, egnite announced the launch of its 2026 Investigator-Initiated Study (IIS) Grant Program, supporting independent research initiatives that have the potential to meaningfully advance cardiovascular patient care and outcomes.

Publish date

February 24, 2026